Bioter S.A. (BIOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bioter S.A. (BIOT) has a cash flow conversion efficiency ratio of 0.023x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.46 Million ≈ $-2.88 Million USD) by net assets (€-106.17 Million ≈ $-124.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bioter S.A. defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Bioter S.A. - Cash Flow Conversion Efficiency Trend (2014–2022)
This chart illustrates how Bioter S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bioter S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioter S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cann Group Ltd
AU:CAN
|
0.000x |
|
Pool Safe Inc
V:POOL
|
-3.557x |
|
Netcapital Inc
NASDAQ:NCPL
|
-0.040x |
|
Conduit Pharmaceuticals Inc.
NASDAQ:CDT
|
-0.015x |
|
ARC Funds Ltd
AU:ARC
|
-0.304x |
|
H&T Group plc
LSE:HAT
|
0.033x |
|
Volcanic Gold Mines Inc
V:VG
|
-0.192x |
|
Sherpa II Holdings Corp
V:SHRP
|
-0.046x |
Annual Cash Flow Conversion Efficiency for Bioter S.A. (2014–2022)
The table below shows the annual cash flow conversion efficiency of Bioter S.A. from 2014 to 2022. For the full company profile with market capitalisation and key ratios, see BIOT company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €-106.17 Million ≈ $-124.12 Million |
€-9.46 Million ≈ $-11.06 Million |
0.089x | +34.82% |
| 2021-12-31 | €-96.49 Million ≈ $-112.81 Million |
€-6.38 Million ≈ $-7.45 Million |
0.066x | -36.34% |
| 2020-12-31 | €-87.69 Million ≈ $-102.52 Million |
€-9.10 Million ≈ $-10.64 Million |
0.104x | +51.53% |
| 2019-12-31 | €-93.64 Million ≈ $-109.48 Million |
€-6.41 Million ≈ $-7.50 Million |
0.068x | -17.40% |
| 2018-12-31 | €-85.02 Million ≈ $-99.39 Million |
€-7.05 Million ≈ $-8.24 Million |
0.083x | -57.38% |
| 2017-12-31 | €-71.39 Million ≈ $-83.47 Million |
€-13.89 Million ≈ $-16.24 Million |
0.195x | +47.08% |
| 2016-12-31 | €-54.16 Million ≈ $-63.32 Million |
€-7.16 Million ≈ $-8.38 Million |
0.132x | -46.53% |
| 2015-12-31 | €-35.44 Million ≈ $-41.43 Million |
€-8.77 Million ≈ $-10.25 Million |
0.247x | -34.62% |
| 2014-12-31 | €-25.33 Million ≈ $-29.61 Million |
€-9.58 Million ≈ $-11.20 Million |
0.378x | -- |
About Bioter S.A.
Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects, such as offices, banks, bus stations, etc. The company was founded in 1961 and is based in Athens, Gree… Read more